Shopping Cart
- Remove All
Your shopping cart is currently empty
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $288 | Backorder | |
| 5 mg | $783 | Backorder |
| Description | Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue. |
| Synonyms | Ac2-26 TFA |
| Molecular Weight | 3203.45 |
| Formula | C143H211F3N32O46S |
| Relative Density. | no data available |
| Sequence | H-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Tyr-NH2 |
| Sequence Short | YNWNSFGLRY |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O: Soluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.